CIBC Bancorp USA’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$6.92M Sell
24,704
-11,102
-31% -$2.92M 0.01% 648
2026
Q1
$9.55M Buy
+35,806
New +$9.7M 0.01% 527
2025
Q3
$3.71M Buy
+12,940
New +$3.47M 0.02% 461

Other funds holding LH

CIBC Bancorp USA's LH Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Labcorp (LH) stake by 31% in Q2 2026, selling an estimated $2.92M and leaving 24,704 shares worth $6.92M. The position accounts for 0.01% of the portfolio, ranked #648.

CIBC Bancorp USA first reported a position in LH in Q3 2025 and has held it in 3 quarters since. The position peaked at $9.55M in Q1 2026. 1,051 funds tracked by Wall St. Rank hold LH as of Q2 2026.

  • CIBC Bancorp USA held 24,704 shares of Labcorp worth $6.92M as of Q2 2026.
  • CIBC Bancorp USA sold 11,102 Labcorp shares in Q2 2026, an estimated $2.92M.
  • Labcorp made up 0.01% of CIBC Bancorp USA's portfolio in Q2 2026, its #648 holding.
  • CIBC Bancorp USA first reported a position in Labcorp in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Labcorp position peaked at $9.55M in Q1 2026.
  • 1,051 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.